Scarica l'app Stockscreener
285.36
1.58%
-4.58
Dopo l'orario di chiusura:
285.00
-0.36
-0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VEEV Giù?
Forum
Previsione
Precedente Chiudi:
$289.94
Aprire:
$289.72
Volume 24 ore:
2.09M
Relative Volume:
1.40
Capitalizzazione di mercato:
$45.71B
Reddito:
$2.86B
Utile/perdita netta:
$780.66M
Rapporto P/E:
60.46
EPS:
4.72
Flusso di cassa netto:
$1.20B
1 W Prestazione:
+2.02%
1M Prestazione:
+22.57%
6M Prestazione:
+13.94%
1 anno Prestazione:
+54.24%
Intervallo 1D:
$284.91
$290.96
Intervallo di 1 settimana:
$275.35
$291.68
Portata 52W:
$176.41
$291.68
Veeva Systems Inc Stock (VEEV) Company Profile
Nome
Veeva Systems Inc
Settore
Industria
Telefono
925-452-6500
Indirizzo
4280 HACIENDA DRIVE, PLEASANTON, CA
Confronta VEEV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
285.36 | 45.71B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
62.07 | 9.42B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
58.85 | 9.78B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
111.55 | 8.70B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
41.16 | 6.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-29 | Reiterato | Needham | Buy |
| 2025-01-23 | Downgrade | Goldman | Buy → Sell |
| 2024-12-20 | Iniziato | Stephens | Overweight |
| 2024-12-04 | Iniziato | Mizuho | Outperform |
| 2024-11-19 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-08 | Iniziato | Exane BNP Paribas | Outperform |
| 2024-08-27 | Reiterato | Citigroup | Buy |
| 2024-07-09 | Iniziato | BTIG Research | Buy |
| 2023-10-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | Iniziato | Jefferies | Buy |
| 2023-06-28 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-03-17 | Downgrade | Truist | Buy → Hold |
| 2023-02-23 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-01-04 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-12-06 | Iniziato | Cowen | Market Perform |
| 2022-12-02 | Reiterato | Needham | Buy |
| 2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-19 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | Iniziato | Oppenheimer | Outperform |
| 2022-06-23 | Iniziato | Goldman | Buy |
| 2022-06-21 | Ripresa | Guggenheim | Buy |
| 2022-03-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-01-28 | Iniziato | Truist | Buy |
| 2022-01-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Ripresa | Stifel | Buy |
| 2021-09-02 | Reiterato | BofA Securities | Buy |
| 2021-09-02 | Reiterato | JMP Securities | Mkt Outperform |
| 2021-09-02 | Reiterato | Needham | Buy |
| 2021-09-02 | Reiterato | UBS | Neutral |
| 2021-07-21 | Iniziato | Cowen | Outperform |
| 2021-03-31 | Aggiornamento | UBS | Sell → Neutral |
| 2021-01-07 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-10-14 | Ripresa | UBS | Sell |
| 2020-08-28 | Reiterato | Needham | Buy |
| 2020-07-23 | Iniziato | FBN Securities | Outperform |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-06-08 | Iniziato | Citigroup | Buy |
| 2020-05-29 | Reiterato | Needham | Buy |
| 2020-04-13 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-02-19 | Iniziato | Robert W. Baird | Outperform |
| 2020-02-14 | Iniziato | Piper Sandler | Overweight |
| 2020-01-13 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | Reiterato | Canaccord Genuity | Hold |
| 2019-09-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | Reiterato | Needham | Buy |
| 2019-06-07 | Iniziato | Goldman | Neutral |
| 2019-05-30 | Reiterato | BofA/Merrill | Buy |
| 2019-05-30 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-27 | Reiterato | Needham | Buy |
Mostra tutto
Veeva Systems Inc Borsa (VEEV) Ultime notizie
Veeva Systems Inc. (VEEV): A Bull Case Theory - Insider Monkey
Alcon: Achieving UDI Compliance with Veeva RIM - Veeva
Do Options Traders Know Something About Veeva Systems Stock We Don't? - TradingView
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know - MSN
Veeva Systems: AI And Vault CRM Are Key Long-Term Tailwinds (NYSE:VEEV) - Seeking Alpha
Transcript : Veeva Systems Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-04-2025 01 - marketscreener.com
Jefferies Hikes Veeva Systems (VEEV) Price Target to $335, Maintains Buy Rating - MSN
Veeva Systems (NYSE:VEEV) Partners With Accumulus Synergy For Global Regulatory Connectivity - Yahoo Finance
Veeva Systems stock soars to 52-week high of $286.99 - Investing.com
Veeva Systems Signs Oncology Trial Software Deal With Sarah Cannon Research Institute - marketscreener.com
VEEV Teams Up with SCRI to Enhance Oncology Clinical Trials | VE - GuruFocus
Astellas Chooses Veeva Vault CRM as Global Standard | VEEV Stock News - GuruFocus
Astellas selects Veeva Vault CRM for global operations By Investing.com - Investing.com Canada
SCRI adopts Veeva platform for streamlined clinical trials By Investing.com - Investing.com Canada
Veeva and Sarah Cannon Research Institute Form Strategic Collaboration to Advance Oncology Clinical Trials | VEEV Stock News - GuruFocus
Accumulus Synergy and Veeva Systems Partner to Advance Regulatory Transformation and Connectivity - marketscreener.com
Astellas Chooses Veeva Vault CRM as Global Standard - marketscreener.com
Veeva and Sarah Cannon Research Institute Form Strategic Collaboration to Advance Oncology Clinical Trials - PR Newswire
Veeva Sees Inflows after Earnings Beat - FXEmpire
Transcript : Veeva Systems Inc. Presents at Baird Global Consumer, Technology & Services Conference 2025, Jun-03-2025 10 - marketscreener.com
Understanding Veeva (VEEV) Reliance on International Revenue - Yahoo Finance
Decoding Veeva Systems Inc (VEEV): A Strategic SWOT Insight - GuruFocus
Insider Sell: Thomas Schwenger Sells 1,150 Shares of Veeva Syste - GuruFocus
VEEVA SYSTEMS INC SEC 10-Q Report - TradingView
Insider Sell: Thomas Schwenger Sells 1,150 Shares of Veeva Systems Inc (VEEV) - GuruFocus
Needham Maintains Buy Rating on Veeva Systems (VEEV), Sets $300 PT - MSN
VEEV: Mizuho Raises Price Target for Veeva Systems with Outperfo - GuruFocus
VEEV: Mizuho Raises Price Target for Veeva Systems with Outperform Rating | VEEV Stock News - GuruFocus
Veeva Systems (VEEV) Gains Price Target Boost Following Strong Q - GuruFocus
Veeva Systems’ Earnings Call Highlights Strong Growth Amid Uncertainty - MSN
Veeva Systems (VEEV) Gains Price Target Boost Following Strong Q1 Report | VEEV Stock News - GuruFocus
Veeva Systems Inc. (VEEV) Stock Analysis: Navigating Growth with a $45.58 Billion Market Cap and Promising 16.7% Revenue Upsurge - DirectorsTalk Interviews
Why Veeva Systems Inc. (VEEV) Surged On Thursday - MSN
Veeva Q1: Just Let Your Winner Run (NYSE:VEEV) - Seeking Alpha
VEEV: Citigroup Raises Price Target for Veeva Systems | VEEV Sto - GuruFocus
William Blair Remains Bullish on Veeva Systems (VEEV) After Solid Q1 - Insider Monkey
Veeva to Present at Upcoming Investor Conferences | VEEV Stock News - GuruFocus
Veeva Strategy EVP and CFO to Share Exclusive Insights at Major June Investment Conferences - Stock Titan
Wells Fargo Raises Veeva (VEEV) Price Target, Maintains Outperform Rating - MSN
Raymond James Keeps Their Buy Rating on Veeva Systems (VEEV) - The Globe and Mail
Veeva Systems (VEEV) Sees Raised Price Target Following Strong Q - GuruFocus
While Wall Street Naps, These 10 Stocks Run Wild - Insider Monkey
Veeva Systems targets 200 Vault CRM customers by next year as AI and Crossix drive momentum - MSN
Veeva Systems (VEEV) Earnings Beat And AI Ambitions Shift The Investment Case - simplywall.st
Nvidia, Salesforce, HP Inc., Tesla, C3.ai, e.l.f. Beauty, Veeva, SentinelOne, and More Movers - Barron's
U.S. Indexes Moved Upward Thursday; Veeva Systems Led Increases - Barron's
Veeva Systems, A Top 2% Stock, Catapults And Breaks Out On Its 'Best First Quarter Ever' - Investor's Business Daily
Veeva Systems Inc. (VEEV) Stock: Surges Over 20% on Strong Q1 2026 Results - CoinCentral
Veeva Systems (NYSE:VEEV) Reports Q1 Growth With Revenue At US$759 Million - simplywall.st
Veeva Systems Analysts Boost Their Forecasts After Better-Than-Expected Earnings - Benzinga
Veeva Earnings: Strong Quarter Fueled by Commercial Excellence Ignites Investor Appetite - Morningstar
Veeva Systems Inc Azioni (VEEV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.81%
1.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):